Obama administration is considering streamlining the approval process for antibiotics.
Helen Boucher: For patients with life-threatening infections, access to new antibiotics is vital.
She says by limiting their use to the sickest of the sick, we can minimize risks of new drugs.
Boucher: We need to encourage more companies to do antibiotic research and development.
